Outlook Therapeutics Stock Discussion

$Outlook Therapeutics (OTLK.US)$ Reuters
1  min ago
Outlook Therapeutics Inc - First Positive Reimbursement Decision Worldwide for Lytenava™; First Launch Anticipated in H1 2025

$Outlook Therapeutics (OTLK.US)$ $3 tonight. A retest at $2.4 yesterday.

$Outlook Therapeutics (OTLK.US)$ 👀potential overnight play of today but I don’t like going long in red day

$Outlook Therapeutics (OTLK.US)$
this company very strong support company. until weight January you can get $5

$Outlook Therapeutics (OTLK.US)$ agen will be come back 5 Dollars

$Outlook Therapeutics (OTLK.US)$ Next week 2.5-3.0, holding till Jan 2025 where they will release 3 month efficacy report.

$Outlook Therapeutics (OTLK.US)$ 🥳🥳

$Outlook Therapeutics (OTLK.US)$ 2? 🤨